Management of women with polycystic ovary syndrome during pregnancy

• Autores: Amy M. Valent, Linda A. Barbour
• Localización: Endocrinology and metabolism clinics of North America, ISSN 0889-8529, Vol. 50, Nº. 1, 2021 (Ejemplar dedicado a: Androgens in Women: Too Much, Too Little, Just Right), págs. 57-69
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • Polycystic ovary syndrome (PCOS) is the most common endocrinopathy among reproductive age women and is associated with subfertility and adverse perinatal outcomes, which may include early pregnancy loss, gestational diabetes mellitus, hypertensive spectrum disorder, preterm birth, fetal growth disorders, and cesarean deliveries. The phenotypic heterogeneity, different diagnostic criteria, and PCOS-related conditions that women enter pregnancy with have limited evidenced-based studies and guidelines to reduce pregnancy complications among this high-risk population. This review summarizes the available evidence on the approach and management of women with PCOS preconception, prenatal, and postpartum.